W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL
|
Back to Search Results |
|
Catalog Number BXA117901J |
Device Problem
Appropriate Term/Code Not Available (3191)
|
Patient Problem
Aneurysm (1708)
|
Event Date 07/10/2023 |
Event Type
Injury
|
Event Description
|
The following was reported to gore: on (b)(6) 2023, this patient underwent endovascular treatment of left internal iliac artery aneurysm using gore® viabahn® vbx balloon expandable endoprosthesis for treatment.When the device was deployed from the left internal iliac artery to the superior gluteal artery, blood pressure decreased.Bleeding was suspected but no obvious vessel injury was identified on the angiography.However, contrast retention from the distal end of the device to the native vessel area was observed, considering that vessel injury occurred distal end of the device during the deployment.For treatment of the injury, unplanned embolization of the left internal iliac artery using avp device was performed.The patient tolerated the procedure.The physician reported that when the device was deployed, about 1 cm distally was poorly dilated, and it seemed to have been dilated more later, possibly causing damage to the vessel as it did so.Additionally, the location where the device was placed seemed a little more distal than where it was initially deployed.2203-a:-other (for use when an appropriate device code cannot be identified) used to capture vessel injury.2203-a:-other used to capture unplanned embolization.
|
|
Manufacturer Narrative
|
C1: cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.H3: code "other" was selected as the medical device remains implanted.Return not possible.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Search Alerts/Recalls
|
|
|